Volume 12, Number 12—December 2006
Research
Influenza, Campylobacter and Mycoplasma Infections, and Hospital Admissions for Guillain-Barré Syndrome, England
Table 1
Condition/pathogen | Mean | SD | Median | 25th percentile | 75th percentile | Minimum | Maximum | 10% range |
---|---|---|---|---|---|---|---|---|
GBS | 21.7 | 6.7 | 21 | 17 | 26 | 6 | 51 | 4.5 |
Campylobacter spp. | 908.2 | 287.5 | 875 | 684 | 1,104 | 296 | 1,737 | 144.1 |
Cytomegalovirus | 23.5 | 7.4 | 22 | 19 | 28 | 6 | 51 | 4.5 |
Epstein-Barr virus | 9.9 | 5.9 | 10 | 6 | 14 | 0 | 33 | 3.3 |
Haemophilus influenzae non-B | 9.2 | 7.0 | 7 | 4 | 12 | 0 | 39 | 3.9 |
H. influenzae B | 1.0 | 1.4 | 0 | 0 | 1 | 0 | 8 | 0.8 |
Mycoplasma pneumoniae | 19.6 | 14.0 | 15 | 9 | 26 | 1 | 77 | 7.6 |
Influenza | 41.4 | 62.4 | 13 | 4 | 50 | 0 | 407 | 40.7 |
A | 30.9 | 54.9 | 9 | 3 | 31 | 0 | 398 | 39.8 |
B | 10.4 | 26.9 | 2 | 1 | 5 | 0 | 188 | 18.8 *GBS, Guillain-Barré syndrome; SD, standard deviation. *GBS, Guillain-Barré syndrome; SD, standard deviation. |
*GBS, Guillain-Barré syndrome; SD, standard deviation.
Page created: October 04, 2011
Page updated: October 04, 2011
Page reviewed: October 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.